标题
Latest developments in targeted therapy for hepatocellular carcinoma
作者
关键词
-
出版物
Expert Review of Anticancer Therapy
Volume 10, Issue 10, Pages 1635-1646
出版商
Informa UK Limited
发表日期
2010-10-13
DOI
10.1586/era.10.146
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- Efficacy and tolerability of bevacizumab plus capecitabine as first-line therapy in patients with advanced hepatocellular carcinoma
- (2010) C-H Hsu et al. BRITISH JOURNAL OF CANCER
- AZD6244 (ARRY-142886) enhances the antitumor activity of rapamycin in mouse models of human hepatocellular carcinoma
- (2010) Hung Huynh CANCER
- Novel inhibitors in development for hepatocellular carcinoma
- (2010) Marcus Alexander Wörns et al. EXPERT OPINION ON INVESTIGATIONAL DRUGS
- Continuous Sunitinib Treatment in Patients with Advanced Hepatocellular Carcinoma: A Swiss Group for Clinical Cancer Research (SAKK) and Swiss Association for the Study of the Liver (SASL) Multicenter Phase II Trial (SAKK 77/06)
- (2010) D. Koeberle et al. ONCOLOGIST
- Sorafenib plus octreotide is an effective and safe treatment in advanced hepatocellular carcinoma: multicenter phase II So.LAR. study
- (2009) Salvatore Del Prete et al. CANCER CHEMOTHERAPY AND PHARMACOLOGY
- Novel Therapeutic Inhibitors of the c-Met Signaling Pathway in Cancer
- (2009) J. P. Eder et al. CLINICAL CANCER RESEARCH
- Insulin-Like Growth Factor-1 Receptor Inhibition Induces a Resistance Mechanism via the Epidermal Growth Factor Receptor/HER3/AKT Signaling Pathway: Rational Basis for Cotargeting Insulin-Like Growth Factor-1 Receptor and Epidermal Growth Factor Receptor in Hepatocellular Carcinoma
- (2009) C. Desbois-Mouthon et al. CLINICAL CANCER RESEARCH
- HCV-related hepatocellular carcinoma: From chronic inflammation to cancer
- (2009) Giuseppe Castello et al. CLINICAL IMMUNOLOGY
- Highlights of regional meeting of Italian Southern Oncological Group (GOIM): focus on hepatocellular carcinoma: biological and clinical background, therapeutic guide-lines and perspectives
- (2009) Raffaele Addeo et al. EXPERT OPINION ON INVESTIGATIONAL DRUGS
- mTOR inhibitors for hepatocellular cancer: a forward-moving target
- (2009) Gerhard Treiber Expert Review of Anticancer Therapy
- Phase II Trial of the Combination of Bevacizumab and Erlotinib in Patients Who Have Advanced Hepatocellular Carcinoma
- (2009) Melanie B. Thomas et al. JOURNAL OF CLINICAL ONCOLOGY
- Efficacy, Safety, and Potential Biomarkers of Sunitinib Monotherapy in Advanced Hepatocellular Carcinoma: A Phase II Study
- (2009) Andrew X. Zhu et al. JOURNAL OF CLINICAL ONCOLOGY
- AZD6244 enhances the anti-tumor activity of sorafenib in ectopic and orthotopic models of human hepatocellular carcinoma (HCC)
- (2009) Hung Huynh et al. JOURNAL OF HEPATOLOGY
- Synergistic interactions between sorafenib and bortezomib in hepatocellular carcinoma involve PP2A-dependent Akt inactivation
- (2009) Kuen-Feng Chen et al. JOURNAL OF HEPATOLOGY
- Safety and efficacy of sunitinib in patients with advanced hepatocellular carcinoma: an open-label, multicentre, phase II study
- (2009) Sandrine Faivre et al. LANCET ONCOLOGY
- Targeting vascular endothelial growth factor receptor-1 and -3 with cediranib (AZD2171): effects on migration and invasion of gastrointestinal cancer cell lines
- (2009) M. P. Morelli et al. MOLECULAR CANCER THERAPEUTICS
- Commentary: Sorafenib--The End of a Long Journey in Search of Systemic Therapy for Hepatocellular Carcinoma, or the Beginning?
- (2009) G. K. Abou-Alfa ONCOLOGIST
- Molecular therapy for the treatment of hepatocellular carcinoma
- (2008) T F Greten et al. BRITISH JOURNAL OF CANCER
- Brivanib Alaninate, a Dual Inhibitor of Vascular Endothelial Growth Factor Receptor and Fibroblast Growth Factor Receptor Tyrosine Kinases, Induces Growth Inhibition in Mouse Models of Human Hepatocellular Carcinoma
- (2008) H. Huynh et al. CLINICAL CANCER RESEARCH
- Molecular targeted therapies in hepatocellular carcinoma
- (2008) Josep M. Llovet et al. HEPATOLOGY
- Effects of the mTOR inhibitor sirolimus in patients with hepatocellular and cholangiocellular cancer
- (2008) Magnus Rizell et al. International Journal of Clinical Oncology
- Efficacy and safety of sorafenib in patients in the Asia-Pacific region with advanced hepatocellular carcinoma: a phase III randomised, double-blind, placebo-controlled trial
- (2008) Ann-Lii Cheng et al. LANCET ONCOLOGY
- Sorafenib in Advanced Hepatocellular Carcinoma
- (2008) Josep M. Llovet et al. NEW ENGLAND JOURNAL OF MEDICINE
- Growth factor receptors and related signalling pathways as targets for novel treatment strategies of hepatocellular cancer
- (2008) Michael Höpfner et al. WORLD JOURNAL OF GASTROENTEROLOGY
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started